AwesomeCapital
Search This Blog
Friday, July 23, 2021
Analyst recommendations
Arvinas gets higher PT from Wedbush due to its collaboration with Pfizer.
Biogen
: Wedbush raises price target to $314 from $312, maintains neutral rating
https://www.marketscreener.com/news/latest/Analyst-recommendations-Apple-Aviva-Biogen-Comerica-Incorporated-Tesla---35930158/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.